FDA Approves Glaxo Drug to Treat Chronic Leukemia
October 27, 2009
Boston (DbTechNo) - The Food and Drug Administration have given approval to a drug called Arzerra, for the treatment of a type of chronic leukemia.
The approval was fast tracked, meaning that it was given priority review status based on the fact that patients with the type of leukemia the drug is approved for have limited treatment options.
Arzerra is made by GlaxoSmithKline, and is approved to treat a type of leukemia known as chronic lymphocytic leukemia, which is a rare blood and bone marrow cancer.
Despite being approved, GlaxoSmithKline will still need to conduct clinical trials on the drug to further insure it works and is safe.
Breaking News
Lil Wayne to be Sentenced in Gun Possession CaseBoston (DbTechNo) - Rapper Lil Wayne will be sentenced today after pleading guilty to gun possession charges. The charges...
Autism Risk Increases in Children with Older MothersBoston (DbTechNo) - When it comes to the risk of a child developing autism a lot depends on the age of his or her mother...
Antidepressant Interfeers With Breast Cancer Drug tamoxifenBoston (DbTechNo) - The antidepressant drug paxil has been shown to interfeer with a leading breast cancer drug called tamoxifen. According...
Comments
All comments are moderated.
If your comment is approved, it will be posted within 24 hours